Unilever weighs Thorne Nutrition bid, shares steady in London trade

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-29, 14:05.

Unilever (GB00BVZK7T90) is reportedly exploring a bid for US-based dietary supplements maker Thorne Nutrition with a potential valuation of up to 4 billion dollars, as indicated in recent London and European equity reports citing sources close to the talks.MarketScreener news overview on Unilever and Thorne The shares trade on the London Stock Exchange under ticker ULVR, with the group a constituent of the FTSE 100 index.

What the deal reports say

According to deal roundups and European equities coverage, Unilever is weighing an offer for Thorne Nutrition that could reach around 4 billion dollars, positioning the consumer goods group against other interested parties such as Haleon in the supplements segment.Reuters report on bidders for Thorne Nutrition The potential transaction would expand Unilever's presence in health-focused products beyond its existing vitamins, minerals and supplements portfolio.

Market commentary from UBS highlights open questions around any Thorne deal, including integration risks and the price tag for a fast-growing but still niche US brand in a competitive supplements market.UBS comments on Unilever deal considerations Analysts point out that Unilever has been pruning parts of its portfolio while selectively adding higher-growth, premium assets.

Where the stock stands now

On the London Stock Exchange, Unilever shares recently traded around 4,600.50 pence, implying a market capitalization of roughly 99 billion pounds and a price-to-earnings ratio near 17.3, per current data from Hargreaves Lansdown.Hargreaves Lansdown share data on ULVR In the US, the American Depositary Receipts under ticker UL closed the last session at about 60.55 dollars, with trading volume around 4.2 million shares.Recent UL ADR price and volume snapshot

Alternative data providers such as AltIndex estimate Unilever's market capitalization around 130 billion dollars, with a current US ADR price close to 60.54 dollars and a price-to-earnings ratio above 20, reflecting a global consumer staples valuation premium.AltIndex statistics on Unilever PLC The shares thus trade in line with large-cap peers like Nestlé and Procter & Gamble in terms of earnings multiples.

The business behind the stock

Unilever generates its revenue primarily from branded fast-moving consumer goods in foods, home care and personal care, with a broad portfolio across Europe, the Americas, Asia and emerging markets.Unilever annual report and portfolio overview Well-known products include Dove personal care lines, Magnum ice cream and Hellmann's condiments, alongside tea and nutrition brands.

Where the Unilever shares trade today

Unilever shares (GB00BVZK7T90) trade on the London Stock Exchange at around 4,600.50 pence as of 2026-06-26, according to the latest available quote data, with the FTSE 100 listing providing liquidity for international investors.Latest ULVR quote and market data

This article is for informational purposes only and does not constitute investment advice, tax advice or a recommendation to buy or sell any security. All data are based on sources believed to be reliable but cannot be guaranteed. Investors should conduct their own research or consult a qualified advisor before making investment decisions.